The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Welcome stories


21 October 2005
21/10/2005 Beximco Pharmaceuticals

The London Stock Exchange is delighted to welcome Beximco Pharmaceuticals (‘BPL’) to AIM.

 

21 October 2005

 

 

BPL is the first Bangladesh incorporated company to join the London markets. 

 

In its home market, BPL is one of the leading generic pharmaceuticals companies, manufacturing and selling generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids.  BPL also manufactures under contract for GlaxoSmithKline and has recently entered into a contract to manufacture for Novartis.  The company’s products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Pakistan, Nepal and Myanmar and in other markets overseas, principally in East Africa (including Kenya) and South East Asia (including Singapore). 

 

BPL is based in Dhaka, Bangladesh, where it operates from a site spanning 20 acres and has over 1800 employees.  The business generated revenues of approximately £23.5 million in 2004 and generated profits after tax of £2.8 million. It has some 50,000 shareholders in its home market and following the placing will have a freefloat of around 80%.

 

Commenting on the flotation on AIM, Nazmul Hassan, Chief Executive of BPL, said:

 

“We are extremely delighted to be joining the AIM market of the London Stock Exchange.  Our objective is to build BPL into a world class manufacturer of pharmaceutical products and the funds raised in the placing will enable us to exploit what we see as a unique opportunity to deliver substantial sales and profit growth for shareholders.”

 

 

 

 

.

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds